gadolinium dtpa has been researched along with deferoxamine in 7 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (deferoxamine) | Trials (deferoxamine) | Recent Studies (post-2010) (deferoxamine) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 6,703 | 240 | 1,266 |
Protein | Taxonomy | gadolinium dtpa (IC50) | deferoxamine (IC50) |
---|---|---|---|
Lysine-specific demethylase 4A | Homo sapiens (human) | 3.275 | |
Deoxyhypusine hydroxylase | Homo sapiens (human) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, AE; Burnett, KR; Cockrill, HH; Kanal, E; Kendall, C; Leese, PT; Lyons, KP; Ross, E; Wolf, GL; Worah, D | 1 |
Gilbert, JJ; Karlik, SJ; Noseworthy, JH; O'Brien, JT | 1 |
Fitzsimmons, J; Guy, J; Mancuso, A; McGorray, S; Qi, X; Rao, N | 1 |
Deslauriers, R; Kozlowski, P; Saunders, JK; Shen, J; Su, S; Sun, J; Tian, G; Xiang, B | 1 |
Antich, P; Chen, H; Constantanescu, A; Dadey, E; Kulkarni, P; Mason, R; Parkey, R; Ranney, D; Singh, O | 1 |
Babos, M; Kardos, L; Marton, B; Palkó, A; Randhawa, MS; Schwarcz, A | 1 |
Contreras, J; Forman, HJ; Leppert, VJ; Nguyen, K; Premasekharan, G; Ramon, V | 1 |
1 trial(s) available for gadolinium dtpa and deferoxamine
Article | Year |
---|---|
Ferrioxamine as a magnetic resonance contrast agent. Preclinical studies and phase I and II human clinical trials.
Topics: Adult; Animals; Contrast Media; Deferoxamine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Ferric Compounds; Gadolinium DTPA; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Male; Mice; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid | 1988 |
6 other study(ies) available for gadolinium dtpa and deferoxamine
Article | Year |
---|---|
NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Deferoxamine; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Gadolinium DTPA; Guinea Pigs; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Spinal Cord; Time Factors | 1987 |
Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Deferoxamine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gadolinium DTPA; Guinea Pigs; Hydrogen Peroxide; Hydroxyethyl Starch Derivatives; Hydroxyl Radical; Immunohistochemistry; Injections, Intraperitoneal; Magnetic Resonance Imaging; Myelin Sheath; Optic Disk; Optic Nerve; Optic Neuritis; Organometallic Compounds; Pentetic Acid | 1994 |
Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion.
Topics: Animals; Contrast Media; Coronary Circulation; Deferoxamine; Drug Combinations; Ferric Compounds; Gadolinium; Gadolinium DTPA; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Magnetic Resonance Angiography; Organometallic Compounds; Pentetic Acid; Perfusion; Swine; Time Factors | 1997 |
Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carbohydrate Sequence; Carbohydrates; Chemistry, Pharmaceutical; Deferoxamine; Dermatan Sulfate; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Gadolinium DTPA; Heparin; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Sequence Data; Neoplasm Transplantation; Neoplasms; Prostatic Neoplasms; Rats | 2005 |
In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
Topics: Administration, Oral; Cacao; Contrast Media; Deferoxamine; Gadolinium DTPA; Gastrointestinal Diseases; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Plant Extracts; Regression Analysis; Ribes; Rosa | 2008 |
Iron-mediated lipid peroxidation and lipid raft disruption in low-dose silica-induced macrophage cytokine production.
Topics: Biomimetic Materials; Bridged-Ring Compounds; Catalase; Cell Line; Chelating Agents; Cytokines; Deferoxamine; Gadolinium DTPA; Humans; Iron; Lipid Peroxidation; Macrophages; Membrane Microdomains; Metalloporphyrins; Microscopy, Electron; Norbornanes; Silicon Dioxide; Thiocarbamates; Thiones; Type C Phospholipases | 2011 |